Table 1.
The clinical characteristics of study participants
Parameters | overall (n = 1447) |
cf-PWV ≥12 (n = 571) |
cf- PWV < 12 (n = 876) |
P value |
---|---|---|---|---|
Age (year) | 61.30 ± 11.4 | 65.59 ± 10.9 | 52.46 ± 11.5 | <0.001 |
Male [n (%)] | 601(41.53) | 270(47.28) | 331(37.78) | <0.001 |
BMI | 25.41 ± 3.32 | 25.41 ± 3.28 | 25.26 ± 4.17 | 0.583 |
Systolic BP(mmHg) | 128.7 ± 17.7 | 135.38 ± 18.37 | 124.37 ± 15.93 | <0.001 |
Diastolic BP(mmHg) | 77.11 ± 10.26 | 77.00 ± 10.92 | 77.18 ± 9.82 | 0.762 |
Fasting glucose (mmol/L) | 5.39 ± 1.65 | 5.63 ± 1.87 | 5.21 ± 1.35 | <0.001 |
2-HpBG(mmol/L) | 6.96 ± 1.11 | 7.71 ± 1.10 | 6.47 ± 1.23 | <0.001 |
Triglyceride(mmol/L) | 1.80 ± 1.24 | 1.92 ± 1.27 | 1.74 ± 1.24 | 0.017 |
Total cholesterol (mmol/L) | 5.01 ± 0.93 | 5.02 ± 0.97 | 5.01 ± 0.89 | 0.845 |
HDL2-C (mg/dL) | 29.85 ± 9.13 | 29.69 ± 9.44 | 30.05 ± 9.08 | 0.593 |
HDL3-C (mg/dL) | 20.98 ± 4.22 | 20.62 ± 4.12 | 21.42 ± 4.38 | 0.006 |
HDL cholesterol (mmol/L) | 1.34 ± 0.42 | 1.30 ± 0.43 | 1.37 ± 0.41 | 0.247 |
LDL cholesterol (mmol/L) | 2.91 ± 0.71 | 2.96 ± 0.73 | 2.87 ± 0.69 | 0.030 |
Waist-hip ratio | 0.87 ± 0.05 | 0.88 ± 0.06 | 0.86 ± 0.0.07 | <0.001 |
eGFR (ml/min) | 94.2 ± 14.3 | 88.18 ± 14.19 | 98.63 ± 12.45 | <0.001 |
Current smoking [n (%)] | 380(26.26) | 175(30.65) | 205(23.40) | <0.001 |
Hypertension [n (%)] | 755(52.17) | 418(73.20) | 337(38.47) | <0.001 |
Diabetes mellitus [n (%)] | 302(20.87) | 183(24.22) | 119(18.45) | <0.001 |
Note: Characteristics are reported as percentages for categorical variables and means (±SD) or median (with interquartile range) for continuous variables. The study participants were divided into two groups based on the level of cf-PWV (≥12, <12). Categorical variablesare presented as counts and percentages. The values outside the parentheses are the number of subjects, and the values inside the parentheses are prevalence
BMI, body mass index; BP, blood pressure; HDL2-C, high-density lipoprotein 2 cholesterol; HDL3-C, high-density lipoprotein 3 cholesterol; LDL, low-density lipoprotein; 2-HpBG, 2-h postload glucose; eGFR, estimated glomerular filtration rate; cf-PWV, carotid-femoral pulse wave velocity